A clinical trial: Aqualizer ™ therapy and its effects on myopathies or temporomandibular dysfunctions. Part II: Subjective parameters

Buchbender M, Keplinger L, Kesting MR, Adler W, Schmitt C (2021)


Publication Type: Journal article

Publication year: 2021

Journal

DOI: 10.1080/08869634.2021.1885887

Abstract

Objective: Temporomandibular dysfunction (TMD) reduces patients’ quality of life (QoL). The aim was to assess the effects of initial Aqualizer™ therapy. Methods: Group 1 (initial Aqualizer™ therapy) before definitive splint therapy or Group 2 (no initial therapy). Patients with arthrosis, partial/total prosthesis, or were undergoing splint therapy were excluded. Subjective parameters were evaluated: duration and intensity of pain, influence on wellbeing, changes in the head/neck area, handling and improvement of the Aqualizer™, improvement in QoL. The statistical significance level was 5% (p < 0.05). Results: In 53 patients (Group 1 n = 25; Group 2 n = 28), the improvement in patients’ well-being and intensity of pain in both groups was significant (p < 0.001). An improvement in QoL was found in 84% of patients in Group 1 and 75% in Group 2. Conclusion: Initial Aqualizer™ therapy can decrease the intensity of pain and increase patients’.

Authors with CRIS profile

How to cite

APA:

Buchbender, M., Keplinger, L., Kesting, M.R., Adler, W., & Schmitt, C. (2021). A clinical trial: Aqualizer ™ therapy and its effects on myopathies or temporomandibular dysfunctions. Part II: Subjective parameters. Cranio-The Journal of Craniomandibular Practice. https://doi.org/10.1080/08869634.2021.1885887

MLA:

Buchbender, Mayte, et al. "A clinical trial: Aqualizer ™ therapy and its effects on myopathies or temporomandibular dysfunctions. Part II: Subjective parameters." Cranio-The Journal of Craniomandibular Practice (2021).

BibTeX: Download